Classifcation of thyroid follicular cell tumors: With special reference to borderline lesions

Endocrine Journal

Volumn 59, Issue 1, 2012, Pages 1-12

  Kakudo, Kennichi ^a   Bai, Yanhua ^b   Liu, Zhiyan ^c   Li, Yaqion ^d   Ito, Yasuhiro ^e   Ozaki, Takashi ^d  

^a KOBE TOKIWA UNIVERSITY   (Japan)

^b PEKING UNIVERSITY CANCER HOSPITAL AND INSTITUTE   (China)

^c SHANDONG UNIVERSITY SCHOOL OF MEDICINE   (China)

^d WAKAYAMA MEDICAL UNIVERSITY   (Japan)

^e KUMA HOSPITAL   (Japan)

Author keywords

Borderline; Diagnosis; Pathology; Prognosis; Thyroid carcinoma

Indexed keywords

RADIOACTIVE IODINE; TUMOR PROTEIN;

ACCESSORY NERVE PARALYSIS; CANCER INCIDENCE; CANCER INVASION; CAPSULAR INVASION ONLY FOLLICULAR THYROID CARCINOMA; CAUSE SPECIFIC SURVIVAL; CRANIAL NERVE PARALYSIS; DISTANT METASTASIS; ENCAPSULATED CONVENTIONAL PAPILLARY THYROID CARCINOMA; ENCAPSULATED FOLLICULAR VARIANT PAPILLARY THYROID CARCINOMA; FACIAL NERVE PARALYSIS; FOLLICULAR TUMOR OF UNCERTAIN MALIGNANT POTENTIAL; HORNER SYNDROME; HUMAN; HYPOPARATHYROIDISM; IMMUNOHISTOCHEMISTRY; LOBECTOMY; LYMPH NODE METASTASIS; MODERATELY DIFFERENTIATED FOLLICULAR CELL ADENOCARCINOMA; NECK DISSECTION; PAPILLARY MICROCARCINOMA; PNEUMOTHORAX; POORLY DIFFERENTIATED THYROID CANCER; PROGNOSIS; RECURRENT LARYNGEAL NERVE PALSY; REVIEW; THYROID FOLLICLE CELL TUMOR; THYROID FOLLICULAR CARCINOMA; THYROID FOLLICULAR CELL TUMOR; THYROID PAPILLARY CARCINOMA; THYROID TUMOR; THYROIDECTOMY; TUMOR CLASSIFICATION; TUMOR RECURRENCE; UNDIFFERENTIATED CARCINOMA; WELL DIFFERENTIATED TUMOR OF UNCERTAIN MALIGNANT POTENTIAL; ADENOCARCINOMA; GENETICS; METABOLISM; PATHOLOGY;

ADENOCARCINOMA, FOLLICULAR; HUMANS; NEOPLASM PROTEINS; PROGNOSIS; THYROID NEOPLASMS;

EID: 84856775828     PISSN: 09188959     EISSN: 13484540     Source Type: Journal    
DOI: 10.1507/endocrj.EJ11-0184     Document Type: Review

References (73)

1. Saxen E, Franssila K, Bjarnason O, et al. (1978) Observer variation in histologic classifcation of thyroid cancer. Acta Pathol Microbiol Scand [A] 86A:483-486.
2. Kakudo K, Katoh R, Sakamoto A et al. (2002) Thyroid gland: international case conference. Endocrine Pathol 13:131-134.
3. Hirokawa M, Carney JA, Goellner JR et al. (2002) Observer variation of encapsulated follicular lesions of the thyroid gland. Am J Surg Pathol 26:1508-1514.
4. Franc B, de la Salmonière P, Lange F et al. (2003) Interobserver and intraobserver reproducibility in the histopathology of follicular thyroid carcinoma Hum Pathol 34:1092-1100.
5. Lloyd RV, Erickson LA, Casey MB, et al. (2004) Observer variation in the diagnosis of follicular variant of papillary thyroid carcinoma. Am J Surg Pathol 28:1336-1340.
6. Elsheikh TM, Asa SL, Chan JK et al. (2008) Interobserver and intraobserver variation among experts in the diagnosis of thyroid follicular lesions with borderline nuclear featuresof papillary carcinoma. Am J Clin Pathol 130:683-686.
7. Ito Y, Yabuta T, Hirokawa M et al. (2008) Distant and lymph node metastasis of thyroid nodules with no pathological evidence of malignancy: A limitation of pathological examination. Endocr J 55:889-894.
8. Rosai J, Carcangiu ML and DeLellis RA (1992) Atlas of Tumor Pathology, Third Series Fascicle 5, Tumors of the Thyroid Gland. American Registry of Pathology, Armed Forces Institute of Pathology, Washington D.C.
9. DeLellis RA, Lloyd RV, Heitz PU and Eng C (2004) Tumours of Endocrine Organs, World Health Organization Classifcation of Tumours; Pathology and Genetics. Lyon: IARC Press.
10. Baloch ZW, LiVolsi VA (2000) Encapsulated follicular variant of papillary thyroid carcinoma with bone metas-tases. Mod Pathol 13:861-865.
11. Kahn A and Nose V (2010) Pathology of thyroid gland. In Endocrine Pathology, differential diagnosis and molecular advances, editor, RV Lloyd, Springer, New York, pp181-236.
12. Franssila KO (1973) Is the differentiation between papillary and follicular thyroid carcinoma valid? Cancer 32:853-864.
13. Widder S, Guggisberg K, Khalil M et al. (2008) A pathologic re-review of follicular thyroid neoplasms: The impact of changing the threshold for the diagnosis of follicular variant of papillary thyroid carcinoma. Surgery 144:80-85.
14. Rosai J (2010) The encapsulated follicular variant of papillary thyroid carcinoma: Back to the drawing board. Endocr Pathol 21:7-11.
15. Liu J, Singh B, Tallini G et al. (2006) Follicular variant of papillary carcinoma. A clinicopathologic study of a problematic entity. Cancer 107:1255-1264.
16. Tielens ET, Sherman SI, Hruban RH et al. (1994) Follicular variant of papillary thyroid carcinoma. A clinicopathologic study. Cancer 73:424-431.
17. Zidan J, Karen D, Stein M et al. (2003) Pure versus fol-licular variant of papillary thyroid carcinoma: clinical features, prognostic factors, treatment, and survival. Cancer 97:1181-1185.
18. Rivera M, Tuttle M, Patel S et al. (2009) Encapsulated papillary thyroid carcinoma: A clinic-pathologic study of 106 cases with emphasis on its morphologic subtypes (histologic growth pattern). Thyroid 19:119-127.
19. Piana S, Frasoldai A, Felice ED et al. (2010) Encapsulated well-differentiated follicular-patterned thyroid carcinoma do not play a signifcant role in the fatality rate from thyroid carcinoma. Am J Surg Pathol 34:868-872.
20. Kakudo K, Bai Y, Katayama S et al. (2009) Classification of follicular cell tumors of the thyroid gland: Analysis involving Japanese patients from one institute. Pathol Int 59: 359-367.
21. Bai Y, Kakudo K, Li Y et al. (2008) Subclassification of non-solid type papillary carcinoma, identifcation of high-risk group in common type. Cancer Sci 99:1908-1915.
22. Ito Y, Hirokawa M, Uruno T et al. (2008) Biological behavior and prognosis of encapsulated papillary carcinoma of the thyroid: Experience of a Japanese Hospital for thyroid care. World J Surg 32:1789-1794.
23. Ito Y, Hirokawa M, Higashiyama T et al. (2007) Prognosis and prognostic factors of follicular carcinoma in Japan: Importance of postoperative pathological examination. World J Surg 31:1417-1424.
24. Sobrinho-Simoes M, Eloy C, Magalhaes J et al. (2011) Follicular thyroid carcinoma, Mod Pathol 24:s10-s18.
25. Naganuma H, Murayama H, Ohtani N et al. (2000) Optically clear nuclei in papillary carcinoma of the thyroid: demonstration of one of the fxation artifacts and its practical usefulness. Pathol Int 50:113-118.
26. Vickery AL (1983) Thyroid papillary carcinoma: pathological and philosophical controversies. Am J Surg Pathol 7:797-803.
27. Chan JK (2002) Strict criteria should be applied in the diagnosis of encapsulated follicular variant of papillary carcinoma. Am J Clin Pathol 117:16-18.
28. Liu Z, Zhou G, Nakamura M et al. (2011) Encapsulated follicular thyroid tumor with equivocal nuclear changes, so-called well-differentiated tumor of uncertain malignant potential: a morphological, immunohistochemical, and molecular appraisal. Cancer Sci 102:288-294.
29. Williams ED: Guest Editorial (2000) Two proposals regarding the terminology of thyroid tumors. Int J Surg Pathol 8: 181-183.
30. Rivera M, Ricarte-Filho J, Patel S, et al. (2010) Encapsulated thyroid tumors of follicular cell origin with high grade features (high mitotic rate/tumor necrosis): a clinicopathologic and molecular study. Hum Pathol 41:172-180.
31. Collini P, Sampietro G, Pilotti S (2004) Extensive vascular invasion is a marker of risk of relapse in encapsulated non-Hurthle cell follicular carcinoma of the thyroid gland: a clinicopathological study of 18 consecutive cases from a single institution with a 11-year median follow-up. Histopathology 44:35-39.
32. Ghossein RA, Hiltzik DH, Carlson DL, et al. (2006) Prognostic factors of recurrence in encapsulated Hurthle cell carcinoma of the thyroid gland: a clinicopathologic study of 50 cases. Cancer 106:1669-1676.
33. Lang W, Choritz H, Hundeshagen H (1986) Risk factors in follicular thyroid carcinomas. A retrospective follow-up study covering a 14-year period with emphasis on morphological fndings. Am J Surg Pathol 10:246-255.
34. D'Avanzo A, Tresseler P, Ituarte PH, et al. (2004) Follicular thyroid carcinoma: Histology and prognosis. Cancer 100:1123-1129.
35. Kakudo K, Tang W, Ito Y, et al. (2004) Papillary carcinoma of the thyroid in Japan: subclassifcation of common type and identifcation of low-risk group. J Clin Pathol 57:1041-1046.
36. Carney JA, Hirokawa M, Lloyd RV, et al. (2008) Hyalinizing trabecular tumors of the thyroid gland are almost all benign. Am J Surg Pathol 32:1877-1889.
37. Zuo H, Tang W, Yasuoka H, et al (2007) A review of 227 cases of small papillary thyroid carcinoma. Eur J Surg Oncol 33:370-375.
38. Sugitani I, Toda K, Yamada K, et al. (2010) Three distinctly different kinds of papillary thyroid microcarci-noma should be recognized: our treatment strategies and outcomes. World J Surg 34:1222-1231.
39. Lang W, Borrusch H, Bauer L (1988) Occult carcinoma of the thyroid. Evaluation of 1020 sequential autopsies. Am J Clin Pathol 90:72-76.
40. Ito Y, Miyauchi A, Inoue H, et al. (2010) An observational trial for papillary thyroid microcarcinoma in Japanese patients. World J Surg 34:28-35.
41. Rosai J, LiVolsi VA, Sobrinho-Simoes M, et al. (2003) Renaming papillary microcarcinoma of the thyroid gland: the Porto proposal. Int J Surg Pathol 11:249-251.
42. Lo C Y, Chan WF, Lang BH, et al. (2006) Papillary microcarcinoma: is there any difference between clinically overt and occult tumors? World J Surg 30:759-766.
43. Hay I, Hutchison ME, Gonzalez-Losada T, et al. (2008) Papillary thyroid microcarcinoma: a study of 900 cases observed in a 60-year period. Surgery 144:980-987.
44. Roti E, Uberti ECD, Bondanelli M, et al. (2008) Thyroid papillary microcarcinoma: descriptive and metananaly-sis study. Eur J Endocrinol 159:659-673.
45. Chow SM, Law SC, Chan JK, et al. (2003) Papillary microcarcinoma of the thyroid - Prognostic signifcance of lymph node metastasis and multifocality. Cancer 98:31-40.
46. Chan JK (1990) Papillary carcinoma of thyroid: classical and variants. Histol Histopathol 5:241-257.
47. Sobrinho-Simoes M, Nesland JM, Johannessen JV (1988) Columnar cell carcinoma. Another variant of poorly differentiated carcinoma of the thyroid. Am J Clin Pathol 89: 264-267.
48. Nikiforov YE, Erickson LA, Nikiforova MN, et al. (2001) Solid variant of papillary thyroid carcinoma: Incidence, clinic-pathologic characteristics, molecular analysis, and biologic behavior. Am J Surg Pathol 25:1478-1484.
49. Asioli S, Erickson LA, Sebo TJ, et al. (2010) Papillary thyroid carcinoma with prominent hobnail features: a new aggressive variant of moderately differentiated papillary carcinoma. A clinicopathologic, immunohis-tochemical, and molecular study of eight cases. Am J Surg Pathol 34:44-52.
50. Franssila KO (1978) Outcome in papillary carcinoma of the thyroid. Ann Chir Gynaecol 67:49-57.
51. Lindsay S (1960) Carcinoma of the thyroid gland: a clinical and pathological study of 293 patients at the University of California Hospital. Springfeld, Charles C Thomas.
52. Chen KT and Rosai J (1977) Follicular variant of thyroid papillary carcinoma: A clinicopathologic study of six cases. Am J Surg Pathol 1:123-130.
53. Hofman V, Lassalle S, Bonnetaud C, et al. (2009) Thyroid tumours of uncertain malignant potential: frequency and diagnostic reproducibility. Virchows Arch 455:21-33.
54. Chetty R (2011) Follicular patterned lesions of the thyroid gland: a practical algorithmic approach. J Clin Pathol 64:737-741.
55. Kloppel G, Perren A, Heitz PU (2004) The gastroentero-pancreatic neuroendocrine cell system and its tumors: the WHO classifcation. Ann N Y Acad Sci 1014:13-27.
56. Renshow A and Gould WG (2002) Why there is the tendency to "overdiagnose" the follicular variant of papillary thyroid carcinoma, Am J Clin Pathol 117:19-21.
57. Nishigaimi C., et al. Cytological features of well-differentiated tumors of uncertain malignant potential: Usefulness of the Bethesda system for thyroid cytopa-thology. (unpublished data)
58. Scognamiglio T, Hyjek E, Kao J, et al. (2006) Diagnostic usefulness of HBME1, Galectin-3, CK18, and CITED1 and evaluation of their expression in encapsulated lesions with questionable features of papillary thyroid carcinoma. Am J Clin Pathol 126: 700-708.
59. Tavassoli FA and Devilee P (2003) Tumours of the breast and female genital organs, World Health Organization Classifcation of Tumours; Pathology and Genetics. Lyon: IARC Press.
60. van Heerden JA, Hay ID, Goellner, JR et al. (1992) Follicular thyroid carcinoma with capsular invasion alone: a nonthreatening malignancy. Surgery 112:1130-1138.
61. Pacini F, Elisei R, Capezzone M, et al. (2001) Contralateral papillary thyroid cancer is frequent at completion thyroidectomy with no difference in low-and high-risk patients. Thyroid 11: 877-881.
62. Albores-Saavedra J, Wu J, Gould E, Vardaman C, et al. (1991) The macrofollicular variant of papillary thyroid carcinoma. A study of 17 cases. Hum Pathol 22:1195-1205.
63. Pandit AA and Phulpagar C (2001) Worrisome histologic alterations following fne needle aspiration of the thyroid. Acta Cytol 45:173-179.
64. Prasad ML, Pellegata NS, Huang Y, et al. (2005) Galectin-3, fbronectin-1, CITED-1, HBME-1 and cytokeratin-19 immunohistochemistry is useful for the differential diagnosis of thyroid tumors. Mod Pathol 18:48-57.
65. Torregrossa L, Faviana P, Camacci T, et al. (2007) Galectin-3 is highly expressed in encapsulated papillary thyroid carcinoma but weakly expressed in cap-sulated type; comparison with Hector Battifora meso-thelial cell-1 immunoreactivity. Human Pathol 38: 1482-1488.
66. Liu YY, Morreau H, Kievit J, et al. (2008) Combined immunostaining with galectin-3, fbronectin-1, Hector Battifora mesothelial-1, cytokeratin-19, peroxisome proliferator-activated receptor-gamma, and sodium/ iodine symporter antibodies for the differential diagnosis of non-medullary thyroid carcinoma. Eur J Endocrinol 158:375-384.
67. Papotti M, Rodriguez J, De Pompa R, et al. (2005) Galectin-3 and HBME-1 expression in well differentiated thyroid tumors with follicular architecture of uncertain malignant potential. Mod Pathol 18:541-546.
68. Coli A, Bigotti G, Parente P, et al. (2007) Atypical thyroid nodules express both HBME-1 and Galectin-3, two phenotypic markers of papillary thyroid carcinoma. J Exp Clin Cancer Res 26:221-227.
69. Nakamura N, Erickson LA, Jin L, et al. (2006) Immunohistochemical separation of follicular variant of papillary thyroid carcinoma from follicular adenoma. Endocr Pathol 17:213-223.
70. Fontaine JF, Mirebeau-Pruiner D, Franc B, et al. (2008) Microarray analysis refnes classifcation of non-medullary thyroid tumours of uncertain malignancy. Oncogene 27: 2228-2236.
71. Pita JM, Banito A, Cavaco BM, et al. (2009) Gene expression profling associated with the progression to poorly differentiated thyroid carcinoma. Br J Cancer 101:1782-1791.
72. Arora N, Scognamiglio T, Lubitz CC, et al. (2009) Identifcation of borderline thyroid tumors by gene expression array analysis. Cancer 115:5421-5431.
73. Castro P, Rebocho AP, Soares RJ, et al. (2006) PAX8-PPARgamma rearrangement is frequently detected in the follicular variant of papillary thyroid carcinoma. J Clin Endocrinol Metab 91:213-220.